Roche Diagnostics Corporation Erg (Epr3864) Pab

Roche Diagnostics Corporation erg (epr3864) pab; monoclonal primary antibody (anti-erg (epr3864)) is directed against the c-terminus of the ets transcription regulator, erg, and is capable of detecting both wildtype erg, and truncated erg resulting from erg gene rearrangement. this antibody exhibits a nuclear staining pattern and may be used to aid in the identification of prostate adenocarcinomas through the detection of truncated erg. the antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue. this product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. this antibody is intended for in vitro diagnostic (ivd) use. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)